(Q39548133)

13 September 2017

1 reference

title

Interactions between mesolimbic dopamine neurons, cholecystokinin, and neurotensin: evidence using in vivo voltammetry (English)

1 reference

13 September 2017

1 reference

Phillips AG

1

1 reference

13 September 2017

Blaha CD

series ordinal

2

1 reference

13 September 2017

Fibiger HC

series ordinal

3

1 reference

13 September 2017

Lane RF

series ordinal

4

1 reference

13 September 2017

language of work or name

English

0 references

publication date

1 January 1988

1 reference

Annals of the New York Academy of Sciences

13 September 2017

published in

1 reference

13 September 2017

volume

537

1 reference

13 September 2017

page(s)

347-361

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42119.X

13 September 2017

1 reference

Interactions between neuropeptides and dopamine neurons in the ventromedial mesencephalon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42119.X

Neurotensin-containing cell bodies, fibers and nerve terminals in the brain stem of the rat: Immunohistochemical mapping

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42119.X

Neurotensin: topographical distribution in rat brain by immunohistochemistry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42119.X

Neurotensin receptors are located on dopamine-containing neurones in rat midbrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42119.X

Effects of systemically administered cholecystokinin-octapeptide on local cerebral metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42119.X

Chemically modified electrode for in vivo monitoring of brain catecholamines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42119.X

In vivo electrochemical analysis of cholecystokinin-induced inhibition of dopamine release in the nucleus accumbens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42119.X

Cholecystokinin-induced inhibition of dopamine neurotransmission: comparison with chronic haloperidol treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42119.X

Interactions of cholecystokinin octapeptide and dopamine on nucleus accumbens neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42119.X

Misleading concepts in the field of brain peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42119.X

Permeability of the blood-brain barrier to neuropeptides: the case for penetration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42119.X

Low doses of apomorphine elicit two opposing influences on dopamine cell electrophysiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42119.X

Does cholecystokinin potentiate dopamine action in the nucleus accumbens?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42119.X

Acute and chronic haloperidol treatment: Comparison of effects on nigral dopaminergic cell activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42119.X

Chronic haloperidol decreases dopamine release in striatum and nucleus accumbens in vivo: depolarization block as a possible mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42119.X

The interaction of neurotensin with dopaminergic pathways in the central nervous system: basic neurobiology and implications for the pathogenesis and treatment of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42119.X

Neurotensin affects hyperactivity but not stereotypy induced by pre and post synaptic dopaminergic stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42119.X

Reversal by cholecystokinin of apomorphine-induced inhibition of dopamine release in the nucleus accumbens of the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42119.X

Chronic treatment with classical and atypical antipsychotic drugs differentially decreases dopamine release in striatum and nucleus accumbens in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42119.X

Inhibition of dopamine release by cholecystokinin: relevance to schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42119.X

Neurotensin blocks certain amphetamine-induced behaviours

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42119.X

10.1111/J.1749-6632.1988.TB42119.X

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference